Treatment of neuroendocrine cancer metastatic to the liver: The role of ablative techniques

T. D. Atwell, J. W. Charboneau, Florencia Que, J. Rubin, B. D. Lewis, D. M. Nagorney, Matthew R Callstrom, M. A. Farrell, Henry Clement Pitot, Timothy James Hobday

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Carcinoid tumors and islet cell neoplasms are neuroendocrine neoplasms with indolent patterns of growth and association with bizarre hormone syndromes. These tumors behave in a relatively protracted and predictable manner, which allows for multiple therapeutic options. Even in the presence of hepatic metastases, the standard of treatment for neuroendocrine malignancy is surgery, either with curative intent or for tumor cytoreduction, i.e., resection of 90% or more of the tumor volume. Image-guided ablation, as either an adjunct to surgery or a primary treatment modality, can be used to treat neuroendocrine cancer metastatic to the liver. Image-guided ablative techniques, including radiofrequency ablation, alcohol injection, and cryoablation, can be used in selected patients to debulk hepatic tumors and improve patient symptoms. Although long-term follow-up data are not available, the surgical literature indicates that significant ablative debulking may improve patient survival. In this review, we discuss metastatic neuroendocrine disease and its treatment options, especially image-guided ablative techniques.

Original languageEnglish (US)
Pages (from-to)409-421
Number of pages13
JournalCardioVascular and Interventional Radiology
Volume28
Issue number4
DOIs
StatePublished - May 2005

Fingerprint

Liver
Neoplasms
Therapeutics
Cryosurgery
Carcinoid Tumor
Tumor Burden
Islets of Langerhans
Alcohols
Hormones
Neoplasm Metastasis
Injections
Survival
Growth

Keywords

  • Ablation
  • Carcinoid
  • Islet cell
  • Metastasis
  • Neuroendocrine cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of neuroendocrine cancer metastatic to the liver : The role of ablative techniques. / Atwell, T. D.; Charboneau, J. W.; Que, Florencia; Rubin, J.; Lewis, B. D.; Nagorney, D. M.; Callstrom, Matthew R; Farrell, M. A.; Pitot, Henry Clement; Hobday, Timothy James.

In: CardioVascular and Interventional Radiology, Vol. 28, No. 4, 05.2005, p. 409-421.

Research output: Contribution to journalArticle

@article{0dfbcd2fc9254475863d2cf9049ad139,
title = "Treatment of neuroendocrine cancer metastatic to the liver: The role of ablative techniques",
abstract = "Carcinoid tumors and islet cell neoplasms are neuroendocrine neoplasms with indolent patterns of growth and association with bizarre hormone syndromes. These tumors behave in a relatively protracted and predictable manner, which allows for multiple therapeutic options. Even in the presence of hepatic metastases, the standard of treatment for neuroendocrine malignancy is surgery, either with curative intent or for tumor cytoreduction, i.e., resection of 90{\%} or more of the tumor volume. Image-guided ablation, as either an adjunct to surgery or a primary treatment modality, can be used to treat neuroendocrine cancer metastatic to the liver. Image-guided ablative techniques, including radiofrequency ablation, alcohol injection, and cryoablation, can be used in selected patients to debulk hepatic tumors and improve patient symptoms. Although long-term follow-up data are not available, the surgical literature indicates that significant ablative debulking may improve patient survival. In this review, we discuss metastatic neuroendocrine disease and its treatment options, especially image-guided ablative techniques.",
keywords = "Ablation, Carcinoid, Islet cell, Metastasis, Neuroendocrine cancer",
author = "Atwell, {T. D.} and Charboneau, {J. W.} and Florencia Que and J. Rubin and Lewis, {B. D.} and Nagorney, {D. M.} and Callstrom, {Matthew R} and Farrell, {M. A.} and Pitot, {Henry Clement} and Hobday, {Timothy James}",
year = "2005",
month = "5",
doi = "10.1007/s00270-004-4082-6",
language = "English (US)",
volume = "28",
pages = "409--421",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Treatment of neuroendocrine cancer metastatic to the liver

T2 - The role of ablative techniques

AU - Atwell, T. D.

AU - Charboneau, J. W.

AU - Que, Florencia

AU - Rubin, J.

AU - Lewis, B. D.

AU - Nagorney, D. M.

AU - Callstrom, Matthew R

AU - Farrell, M. A.

AU - Pitot, Henry Clement

AU - Hobday, Timothy James

PY - 2005/5

Y1 - 2005/5

N2 - Carcinoid tumors and islet cell neoplasms are neuroendocrine neoplasms with indolent patterns of growth and association with bizarre hormone syndromes. These tumors behave in a relatively protracted and predictable manner, which allows for multiple therapeutic options. Even in the presence of hepatic metastases, the standard of treatment for neuroendocrine malignancy is surgery, either with curative intent or for tumor cytoreduction, i.e., resection of 90% or more of the tumor volume. Image-guided ablation, as either an adjunct to surgery or a primary treatment modality, can be used to treat neuroendocrine cancer metastatic to the liver. Image-guided ablative techniques, including radiofrequency ablation, alcohol injection, and cryoablation, can be used in selected patients to debulk hepatic tumors and improve patient symptoms. Although long-term follow-up data are not available, the surgical literature indicates that significant ablative debulking may improve patient survival. In this review, we discuss metastatic neuroendocrine disease and its treatment options, especially image-guided ablative techniques.

AB - Carcinoid tumors and islet cell neoplasms are neuroendocrine neoplasms with indolent patterns of growth and association with bizarre hormone syndromes. These tumors behave in a relatively protracted and predictable manner, which allows for multiple therapeutic options. Even in the presence of hepatic metastases, the standard of treatment for neuroendocrine malignancy is surgery, either with curative intent or for tumor cytoreduction, i.e., resection of 90% or more of the tumor volume. Image-guided ablation, as either an adjunct to surgery or a primary treatment modality, can be used to treat neuroendocrine cancer metastatic to the liver. Image-guided ablative techniques, including radiofrequency ablation, alcohol injection, and cryoablation, can be used in selected patients to debulk hepatic tumors and improve patient symptoms. Although long-term follow-up data are not available, the surgical literature indicates that significant ablative debulking may improve patient survival. In this review, we discuss metastatic neuroendocrine disease and its treatment options, especially image-guided ablative techniques.

KW - Ablation

KW - Carcinoid

KW - Islet cell

KW - Metastasis

KW - Neuroendocrine cancer

UR - http://www.scopus.com/inward/record.url?scp=24044512977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044512977&partnerID=8YFLogxK

U2 - 10.1007/s00270-004-4082-6

DO - 10.1007/s00270-004-4082-6

M3 - Article

C2 - 16041556

AN - SCOPUS:24044512977

VL - 28

SP - 409

EP - 421

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 4

ER -